Detalles de la búsqueda
1.
High Dose "HDR-Like" Prostate SBRT: PSA 10-Year Results From a Mature, Multi-Institutional Clinical Trial.
Front Oncol
; 12: 935310, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35965547
2.
Dynamic gadolinium-enhanced perfusion MRI of prostate cancer: assessment of response to hypofractionated robotic stereotactic body radiation therapy.
AJR Am J Roentgenol
; 197(4): 907-15, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21940578
3.
Prostate Stereotactic Body Radiation Therapy: An Overview of Toxicity and Dose Response.
Int J Radiat Oncol Biol Phys
; 110(1): 237-248, 2021 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33358229
4.
Tumor Control Probability Modeling and Systematic Review of the Literature of Stereotactic Body Radiation Therapy for Prostate Cancer.
Int J Radiat Oncol Biol Phys
; 110(1): 227-236, 2021 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32900561
5.
Stereotactic Body Radiotherapy for High-Risk Localized Carcinoma of the Prostate (SHARP) Consortium: Analysis of 344 Prospectively Treated Patients.
Int J Radiat Oncol Biol Phys
; 110(3): 731-737, 2021 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33493615
6.
Toxicity After Stereotactic Body Radiation Therapy for Prostate Cancer in Patients With Inflammatory Bowel Disease: A Multi-institutional Matched Case-Control Series.
Adv Radiat Oncol
; 6(6): 100759, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34585025
7.
Salvage stereotactic body radiotherapy (SBRT) for intraprostatic relapse after prostate cancer radiotherapy: An ESTRO ACROP Delphi consensus.
Cancer Treat Rev
; 98: 102206, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33965893
8.
Dose-response with stereotactic body radiotherapy for prostate cancer: A multi-institutional analysis of prostate-specific antigen kinetics and biochemical control.
Radiother Oncol
; 154: 207-213, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33035622
9.
Testosterone Levels and Sexual Quality of Life After Stereotactic Body Radiation Therapy for Prostate Cancer: A Multi-Institutional Analysis of Prospective Trials.
Int J Radiat Oncol Biol Phys
; 105(1): 149-154, 2019 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31108142
10.
Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer.
JAMA Netw Open
; 2(2): e188006, 2019 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30735235
11.
Virtual HDR CyberKnife treatment for localized prostatic carcinoma: dosimetry comparison with HDR brachytherapy and preliminary clinical observations.
Int J Radiat Oncol Biol Phys
; 70(5): 1588-97, 2008 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18374232
12.
A Pooled Analysis of Biochemical Failure in Intermediate-risk Prostate Cancer Following Definitive Stereotactic Body Radiotherapy (SBRT) or High-Dose-Rate Brachytherapy (HDR-B) Monotherapy.
Am J Clin Oncol
; 41(5): 502-507, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27322703
13.
Patient and Dosimetric Predictors of Genitourinary and Bowel Quality of Life After Prostate SBRT: Secondary Analysis of a Multi-institutional Trial.
Int J Radiat Oncol Biol Phys
; 102(5): 1430-1437, 2018 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30056080
14.
Phase 2 Multicenter Trial of Heterogeneous-dosing Stereotactic Body Radiotherapy for Low- and Intermediate-risk Prostate Cancer: 5-year Outcomes.
Eur Urol Oncol
; 1(6): 540-547, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31158102
15.
Computed tomography-ultrasound fusion brachytherapy: description and evolution of the technique.
Brachytherapy
; 6(4): 272-9, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17964222
16.
CT-ultrasound fusion prostate brachytherapy: a dynamic dosimetry feedback and improvement method. A report of 54 consecutive cases.
Brachytherapy
; 4(3): 207-16, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-16182221
17.
Editorial: The Evolving Landscape of Stereotactic Body Radiation Therapy for the Management of Prostate Cancer.
Front Oncol
; 10: 627686, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33384965
18.
High-dose-rate stereotactic body radiation therapy for postradiation therapy locally recurrent prostatic carcinoma: Preliminary prostate-specific antigen response, disease-free survival, and toxicity assessment.
Pract Radiat Oncol
; 5(6): e615-23, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26059509
19.
Prostate brachytherapy seed migration and dosimetry: analysis of stranded sources and other potential predictive factors.
Brachytherapy
; 3(1): 10-9, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15110308
20.
Regarding relative toxicities of stereotactic body radiation therapy versus intensity-modulated radiation therapy for prostate cancer.
J Clin Oncol
; 32(30): 3455-6, 2014 Oct 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-25185083